Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRemoved the government funding lapse notice banner from the page. The study details and trial information remain unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedResults Submitted is now displayed in place of No Results Posted, indicating that the trial results have been submitted for publication.SummaryDifference0.0%

- Check17 days agoChange DetectedNo additions or deletions were detected in the Study Details page for NCT03602859; the content and layout appear unchanged.SummaryDifference0.2%

- Check46 days agoChange DetectedAdds v3.2.0 and removes a specific disease resource (Ovarian cancer); minor content scope change and update history.SummaryDifference0.2%

- Check47 days agoChange DetectedUpdate to version v3.1.0; removal of the specific resource entry for Ovarian cancer from Genetic and Rare Diseases Information Center resources.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page was updated from v3.0.1 to v3.0.2, indicating a minor revision. The 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.